SCN5A (sodium voltage-gated channel alpha subunit 5)

2007-02-01  

Identity

HGNC
LOCATION
3p22.2
LOCUSID
ALIAS
CDCD2,CMD1E,CMPD2,HB1,HB2,HBBD,HH1,ICCD,IVF,LQT3,Nav1.5,PFHB1,SSS1,VF1

Other Information

Locus ID:

NCBI: 6331
MIM: 600163
HGNC: 10593
Ensembl: ENSG00000183873

Variants:

dbSNP: 6331
ClinVar: 6331
TCGA: ENSG00000183873
COSMIC: SCN5A

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000183873ENST00000327956A3EY21
ENSG00000183873ENST00000333535Q14524
ENSG00000183873ENST00000413689H9KVD2
ENSG00000183873ENST00000414099E9PG18
ENSG00000183873ENST00000423572Q14524
ENSG00000183873ENST00000425664E9PG18
ENSG00000183873ENST00000449557A0A0A0MT39
ENSG00000183873ENST00000450102K4DIA1
ENSG00000183873ENST00000451551K4DIA1
ENSG00000183873ENST00000455624E9PHB6
ENSG00000183873ENST00000612060Q86V90

Expression (GTEx)

0
5
10
15
20
25
30
35
40

Pathways

PathwaySourceExternal ID
Adrenergic signaling in cardiomyocytesKEGGhsa04261
Adrenergic signaling in cardiomyocytesKEGGko04261
Muscle contractionREACTOMER-HSA-397014
Developmental BiologyREACTOMER-HSA-1266738
Axon guidanceREACTOMER-HSA-422475
L1CAM interactionsREACTOMER-HSA-373760
Interaction between L1 and AnkyrinsREACTOMER-HSA-445095
Cardiac conductionREACTOMER-HSA-5576891
Phase 0 - rapid depolarisationREACTOMER-HSA-5576892

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA10389non-selective monoamine reuptake inhibitorsChemicalVipGeneassociated
PA159018367Brugada syndromeDiseaseDataAnnotation, Literature, VariantAnnotation, VipGeneassociatedPD23788249, 31484910
PA165819248SCN5A Haplotype BHaplotypeVipGeneassociated16415376
PA166156333rs1805124VariantVipGeneassociated14500339, 15851227, 11997281
PA166156414rs6791924VariantVipGeneassociated15851227, 11997281
PA166186035pilsicainideChemicalVariantAnnotationassociatedPD31484910
PA212KCNH2GeneDataAnnotationassociated
PA223KCNQ1GeneDataAnnotationassociated
PA443459Atrial FibrillationDiseaseVariantAnnotationassociatedPD31484910
PA444366Heart BlockDiseaseVipGeneassociated
PA444807Long QT SyndromeDiseaseVipGeneassociated
PA445659Sick Sinus SyndromeDiseaseVipGeneassociated
PA445769Sudden Infant DeathDiseaseVipGeneassociated
PA446028Ventricular FibrillationDiseaseVariantAnnotation, VipGeneassociatedPD31484910
PA447184Romano-Ward SyndromeDiseaseDataAnnotationassociated
PA448383amiodaroneChemicalVipGeneassociated
PA449072cocaineChemicalVipGeneassociated
PA449373disopyramideChemicalVipGeneassociated
PA449646flecainideChemicalVipGeneassociated
PA450226lidocaineChemicalVipGeneassociated
PA450243lithiumChemicalVipGeneassociated
PA450488mexiletineChemicalVipGeneassociated
PA451108procainamideChemicalVipGeneassociated
PA451131propafenoneChemicalVipGeneassociated
PA451209quinidineChemicalVipGeneassociated

References

Pubmed IDYearTitleCitations
111366912001Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.322
193054082009Common variants at ten loci influence QT interval duration in the QTGEN Study.190
200620602010Genome-wide association study of PR interval.185
201292832010An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.181
158404762005Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.177
193054092009Common variants at ten loci modulate the QT interval duration in the QTSCD Study.162
155795342004Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes.141
156714292005Sodium channel mutations and susceptibility to heart failure and atrial fibrillation.138
160618512005Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis.128
121937832002Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia.127

Citation

Dessen P

SCN5A (sodium voltage-gated channel alpha subunit 5)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/45877/scn5a